Symposium:
4. RCT That Will Change Your Practice
Wednesday, October 3, 2018: 1:30 PM-3:15 PM
Room: N 25

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss recent data from randomized controlled trials in the area of antifungals
  • discuss recent data from randomized controlled trials in the area of antivirals
  • discuss recent data from randomized controlled trials in the area of antibacterials

Target Audience: Clinicians, Fellows, Infectious diseases pediatricians, Infectious diseases physicians

Tracks: Trainee, Pediatric ID, Adult ID


Moderators:  David Van Duin, MD, PhD, University of North Carolina at Chapel Hill and Francisco Marty, MD, Brigham and Women's Hospital

Presentations:
1:30 PM
8

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.75 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-182-L01-P

Disclosures:

D. Van Duin, achaogen: Scientific Advisor , Consulting fee . shionogi: Scientific Advisor , Consulting fee . Allergan: Scientific Advisor , Consulting fee . Astellas: Scientific Advisor , Consulting fee . Neumedicine: Scientific Advisor , Consulting fee . Roche: Scientific Advisor , Consulting fee . T2 Biosystems: Scientific Advisor , Consulting fee .

F. Marty, Ansun: Investigator , Research support . Chimerix: Consultant and Investigator , Consulting fee and Research support . Cidara: Investigator , Research support . Fate Therapeutics: Consultant , Consulting fee . Gilead: Investigator , Research support . GlaxoSmithKline: Consultant , Consulting fee . Merck: Consultant and Investigator , Consulting fee and Research support . Roche Molecular Systems: Consultant , Consulting fee . Shire: Consultant and Investigator , Consulting fee and Research support .

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.